scispace - formally typeset
J

Jianfei Yang

Researcher at GlaxoSmithKline

Publications -  78
Citations -  5164

Jianfei Yang is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Computer science & T cell. The author has an hindex of 20, co-authored 39 publications receiving 4560 citations. Previous affiliations of Jianfei Yang include Niigata University & Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells

TL;DR: T-bet is induced by IFN-γ and STAT1 signaling during T cell activation and mediates STAT1-dependent processes of TH1 development, including the induction of IL-12Rβ2.
Journal ArticleDOI

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

TL;DR: BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), and BTLA-deficient mice have increased specific antibody responses and enhanced sensitivity to experimental autoimmune encephalomyelitis.
Journal ArticleDOI

Signaling and Transcription in T Helper Development

TL;DR: What has emerged is a richly detailed tapestry of signaling and transcription, controlling an important T cell developmental switch, particularly by the strongly polarizing cytokines IL-12 and IL-4.
Journal ArticleDOI

Targeting Th17 cells in autoimmune diseases.

TL;DR: The rationale for targeting two checkpoints in the development and inflammatory function of Th17 cells, retinoid-related orphan receptor-γt (RORγt) and IL-23, and the development of both RORγt small molecule inhibitors andIL-23 neutralizing antibodies is discussed.